Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer

Figure 4

Survival analysis of MAL2 expression in terms of overall survival. Kaplan—Meier survival curve analysis of all tumors (a), subgroup analysis of old patients (b), clinical stage I/II and III/IV (c and d), subgroup analysis of T classification (T1/T2 and T3/T4) (e and f), patients with lymphatic invasion (g), patients with nondistant metastasis (h), and patients with ER-, PR-, and HER2-positive status (i—k, respectively).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)